Literature DB >> 18336594

Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.

J W Eijgenraam1, B D Oortwijn, S W A Kamerling, J W de Fijter, A W L van den Wall Bake, M R Daha, C van Kooten.   

Abstract

Secretory immunoglobulin A (SIgA), although generated at mucosal surfaces, is also found in low concentrations in the circulation. Recently, SIgA was demonstrated in mesangial deposits of patients with immunoglobulin A nephropathy (IgAN), suggesting a role in the pathogenesis. This finding is in line with the belief that high molecular weight (HMW) immunoglobulin A (IgA) is deposited in the kidney. However, there is little information on the size distribution of antigen-specific IgA in circulation upon mucosal challenge. In this study we measured antigen-specific IgA, including SIgA, in serum following challenge of IgAN patients and controls via intranasal vaccination with a neoantigen, cholera toxin subunit B (CTB). We size-fractionated serum and nasal washes to study the size distribution of total IgA, SIgA and CTB-specific IgA. Finally, we compared the size distribution of antigen-specific IgA after mucosal immunization with the distribution upon systemic immunization. A significant induction of antigen-specific SIgA was detectable in serum of both patients with IgAN and controls after mucosal immunization with CTB. Independent of the route of immunization, in both groups the antigen-specific IgA response was predominantly in the polymeric IgA fractions. This is in contrast to total IgA levels in serum that are predominantly monomeric. We conclude that mucosal challenge results in antigen-specific SIgA in the circulation, and that the antigen-specific IgA response in both IgAN patients and in controls is of predominantly HMW in nature. No differences between IgAN patients and controls were detected, suggesting that the size distribution of antigen-specific IgA in the circulation is not disturbed specifically in IgAN patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336594      PMCID: PMC2384095          DOI: 10.1111/j.1365-2249.2008.03616.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.

Authors:  S Suzuki; H Kobayashi; H Sato; M Arakawa
Journal:  Clin Nephrol       Date:  1990-02       Impact factor: 0.975

2.  Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy.

Authors:  L Layward; A C Allen; S J Harper; J M Hattersley; J Feehally
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

3.  Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy.

Authors:  J W de Fijter; J W Eijgenraam; C A Braam; J Holmgren; M R Daha; L A van Es; A W van den Wall Bake
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

4.  Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy.

Authors:  Y Hiki; T Kokubo; H Iwase; Y Masaki; T Sano; A Tanaka; K Toma; K Hotta; Y Kobayashi
Journal:  J Am Soc Nephrol       Date:  1999-04       Impact factor: 10.121

5.  Systemic immune response after mucosal immunization in patients with IgA nephropathy.

Authors:  F B Waldo
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

Review 6.  Structural features of IgA molecules which contribute to IgA nephropathy.

Authors:  J Feehally; A C Allen
Journal:  J Nephrol       Date:  1999 Mar-Apr       Impact factor: 3.902

7.  Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy.

Authors:  J I Roodnat; J W de Fijter; C van Kooten; M R Daha; L A van Es
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

8.  The clinical course of mesangial IgA associated nephropathy in adults.

Authors:  K M Nicholls; K F Fairley; J P Dowling; P Kincaid-Smith
Journal:  Q J Med       Date:  1984

9.  Detection of polymeric IgA in glomeruli from patients with IgA nephropathy.

Authors:  Y Tomino; H Sakai; M Miura; M Endoh; Y Nomoto
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

10.  Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy.

Authors:  L Layward; A M Finnemore; A C Allen; S J Harper; J Feehally
Journal:  Clin Immunol Immunopathol       Date:  1993-12
View more
  6 in total

1.  Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.

Authors:  Daniel Herrera; Camilo Vásquez; Blaise Corthésy; Manuel A Franco; Juana Angel
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

Review 2.  The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.

Authors:  Luis Sanchez-Russo; Arun Rajasekaran; Sofia Bin; Jeremiah Faith; Paolo Cravedi
Journal:  Kidney360       Date:  2022-06-27

3.  Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.

Authors:  Shomi Oka; Takashi Higuchi; Hiroshi Furukawa; Kota Shimada; Akira Okamoto; Atsushi Hashimoto; Akiko Komiya; Koichiro Saisho; Norie Yoshikawa; Masao Katayama; Toshihiro Matsui; Naoshi Fukui; Kiyoshi Migita; Shigeto Tohma
Journal:  BMC Musculoskelet Disord       Date:  2022-01-13       Impact factor: 2.362

4.  Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking.

Authors:  Karin Roos; Klara Martinsson; Michael Ziegelasch; Yngve Sommarin; Anna Svärd; Thomas Skogh; Alf Kastbom
Journal:  Arthritis Res Ther       Date:  2016-05-23       Impact factor: 5.156

Review 5.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561

6.  Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.

Authors:  Karin Roos Ljungberg; Vijay Joshua; Thomas Skogh; Anders Eklund; C Magnus Sköld; Reza Karimi; Sven Nyrén; Anna Svärd; Anca I Catrina; Alf Kastbom
Journal:  Rheumatology (Oxford)       Date:  2020-04-01       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.